Copaxone
Links shared publicly online about this topic
Copaxone gains expanded indication - MPR
empr.com — “The FDA has approved an expanded indication for Copaxone (glatiramer acetate injection, from Teva) to include the treatment of patients who have experienced a first clinical episode and have magnetic resonance imaging (MRI) features consistent with multiple sclerosis (MS).” View full resource at empr.com
Most Recently Shared on March 3, 2009 at 9:23 pm By:
Copaxone gains expanded indication: The FDA has approved an expanded indication for Copaxone (glatiramer acetate.. http://tinyurl.com/agh5sm
Multiple Sclerosis Resource Centre COPAXONE
msrc.co.uk — “The home site of the Multiple Sclerosis Resource Centre, Multiple Sclerosis, Multiple Sclerosis Resource Centre, MSRC, Telephone Counselling Service, 24hour, MS, Health, Disabled, Myelin, MRI, Physically Disabled, Service, MS Drugs, MS News, Beta Interferon, Disability, MS Research, Best Bet Diet, BBD, Discussion Boards, Support, immunology, onset symptoms, warning signs, early symptoms, nutrition, symptoms, treatment, diagnosis, history, COPAXONE” View full resource at msrc.co.uk
Most Recently Shared on June 22, 2010 at 7:40 am By:
George Jelinek Doctor, Emergency Physician, and Physician
Copaxone twice weekly seems to work: one wonders whether Copaxone might be even more helpful if given less frequently http://bit.ly/cUWIVK
Copaxone market share drops in November - Globes
globes.co.il — “Copaxone market share drops in November - Globes” View full resource at globes.co.il
Most Recently Shared on December 19, 2010 at 4:16 pm By:
Copaxone market share drops in November: The figures for Novartis AG's newly launched oral multiple sclerosis tr... http://bit.ly/hWPNHS
Teva Is Spanked By FDA For Copaxone Promotion // Pharmalot
pharmalot.com — “Teva Is Spanked By FDA For Copaxone Promotion // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on March 19, 2012 at 1:41 pm By:
Teva is Spanked by the FDA for its Copaxone promotions .. http://t.co/M97ZqHZs #pharma #socpharm #socmedia
Copaxone competitor expecting FDA approval today - Globes
globes.co.il — “Copaxone competitor expecting FDA approval today - Globes” View full resource at globes.co.il
Most Recently Shared on September 21, 2010 at 8:04 pm By:
Copaxone competitor expecting FDA approval today: Novartis oral multiple sclerosis treatment Gilenia is expected t... http://bit.ly/c7lBZ5
Copaxone competitors report positive results - Globes
globes.co.il — “Copaxone competitors report positive results - Globes” View full resource at globes.co.il
Most Recently Shared on April 11, 2011 at 2:30 pm By:
Copaxone competitors report positive results: Novartis and Biogen Idec presented Phase III study results of thei... http://bit.ly/g1rL7L
FDA to rule Monday on Copaxone competitor - Globes
globes.co.il — “FDA to rule Monday on Copaxone competitor - Globes” View full resource at globes.co.il
Most Recently Shared on February 27, 2011 at 2:23 pm By:
FDA to rule Monday on Copaxone competitor: Teva expects the FDA to reject Merck KGaA's application for a multipl... http://bit.ly/dKH3gS
Teva wins ruling on Copaxone patent lawsuit - Globes
globes.co.il — “Teva wins ruling on Copaxone patent lawsuit - Globes” View full resource at globes.co.il
Most Recently Shared on August 30, 2011 at 12:50 pm By:
Mylan has to fight Teva lawsuit over Copaxone patent-infringement claims. Trial set for 9/7. http://t.co/xothaNl $TEVA $MYL #pharma
Copaxone patent court hearing opens Wednesday - Globes
globes.co.il — “Copaxone patent court hearing opens Wednesday - Globes” View full resource at globes.co.il
Most Recently Shared on September 6, 2011 at 2:05 pm By:
Copaxone patent court hearing opens Wednesday: Teva is suing several companies seeking to develop generic versio... http://t.co/CM8qW0u
Article > Teva defense of Copaxone starts today
pharmatimes.com — “Article > Teva defense of Copaxone starts today” View full resource at pharmatimes.com
Most Recently Shared on September 7, 2011 at 1:15 pm By:
Teva's Copaxone patent defense starts. $TEVA 's also fighting FDA, says $1.68 bn drug too-complex-to-copy http://t.co/P6eatc8 #pharma
Teva Announces Copaxone(R) Reaches One Million Patient Years Of Experience In The Treatment Of Multiple Sclerosis
medicalnewstoday.com — “Teva Pharmaceutical Industries, Ltd. (NASDAQ: TEVA) announced today that Copaxone® (glatiramer acetate injection), has now achieved one million patient years of experience in the treatment of” View full resource at medicalnewstoday.com
Most Recently Shared on April 14, 2010 at 4:07 am By:
Teva Announces Copaxone(R) Reaches One Million Patient Years Of Experience In The Treatment Of Multiple Sclerosis Teva .. http://dld.bz/ajej
Long-Term Study With COPAXONE(R) Indicated Protective Effect On Brain Tissue In Multiple Sclerosis Patients
medicalnewstoday.com — “New data presented provided evidence that long-term treatment with COPAXONE® (glatiramer acetate injection) may offer sustained protection from neuronal/axonal injury. This protective effect w” View full resource at medicalnewstoday.com
Most Recently Shared on April 30, 2009 at 1:36 pm By:
MedNewsToday: Long-Term Study With COPAXONE(R) Indicated Protective Effect On Brain Tissue In Multi.. http://tinyurl.com/czat3v
Multiple Sclerosis - Taking Copaxone to Treat My MS
healthcentral.com — “The decision to use or not use a disease-modifying treatment is a personal one between yourself, your family, and your doctor. Some patients decide to jump in and get started and others wait to see how their MS is going to progress.” View full resource at healthcentral.com
Most Recently Shared on March 19, 2009 at 8:52 pm By:
Taking Copaxone to Treat My MS: The decision to use or not use a disease-modifying treatment is a personal one b.. http://tinyurl.com/cayl3b
PharmaLive: Copaxone Market Share Drops in November
pharmalive.com — “PharmaLive: Copaxone Market Share Drops in November” View full resource at pharmalive.com
Most Recently Shared on December 20, 2010 at 7:28 pm By:
PharmaLive Pharma and Health News
Daily Advantage - Gilenya Hits Copaxone, Tysabri Market Share - http://tinyurl.com/2bq69gy
Teva net climbs 58% as Copaxone sales rise - MarketWatch
marketwatch.com — “Teva Pharmaceutical Industries Ltd. on Tuesday reported first-quarter net income rose 58%, helped by continued strong sales results from multiple-sclerosis drug Copaxone.” View full resource at marketwatch.com
Most Recently Shared on May 4, 2010 at 12:58 pm By:
MarketWatch: Teva net up on sales of Copaxone and generic Mirapex. http://bit.ly/8ZYLVK
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
George Jelinek
Medical professor, MS survivor/researcher/author of Overcoming Multiple Sclerosis, medical journal editor
-
OrganizedWisdom MS
Organizing multiple sclerosis resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
